Foghorn Therapeutics Inc.

📍 Cambridge, United States🗓 Founded 2016👥 129 employees💰 Last funded Sep 2023
Biotechnology Research🌐 foghorntx.com
Website LinkedIn
Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. 
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Foghorn Therapeutics Inc.?
Foghorn Therapeutics Inc. has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Foghorn Therapeutics Inc. last raise funding?
The most recent investment in Foghorn Therapeutics Inc. recorded on gritt.io was in September 2023.
When was Foghorn Therapeutics Inc. founded?
Foghorn Therapeutics Inc. was founded in 2016.
What industry is Foghorn Therapeutics Inc. in?
Foghorn Therapeutics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Foghorn Therapeutics Inc. based?
Foghorn Therapeutics Inc. is headquartered in Cambridge, United States.